Large pieces of DNA from the chromosomes of numerous organisms, including the human, are faithfully propagated in bacteria as large extra-chromosomal plasmids known as Bacterial Artificial Chromosomes (BACs). Because they represent tiny contiguous pieces of the chromosome, BACs are ideally suited for expression of genes in their chromosomal contexts. Genes in BACs need to be functionalized with reporter genes and other sequences that allow easy monitoring, stable maintenance and propagation of the DNA in the new host organism. BAC DNA can be altered within its bacterial host in several ways. One approach uses Tn10 mini-transposons to introduce exogenous DNA into BACs for a variety of purposes. The random insertions of Tn10 transposons carrying lox sites have helped position mammalian cellselectable antibiotic resistance genes, enhancer-traps and inverted repeat end-sequences of the vertebrate transposon Tol2 precisely at the ends of genomic DNA inserts in BACs. Functional identification of generegulatory elements through reporter gene expression and BAC DNA integration into zebrafish or mouse chromosomes have been facilitated with such retrofitting. The methodology has been used extensively to dissect the regulation of the Amyloid Precursor Protein (appb) gene in zebrafish. Functional identification of long-range regulatory sequences of appb has provided important clues for regulation of the APP gene in humans.
Proteins that bind DNA interact with different sequences with varying strengths. Histone proteins in nucleosomes do not have strong preference for binding to a specific sequence, although they exhibit subtle biases that tend to phase them appropriately with other transcription factors regulating the expression of a gene [1, 2] . By contrast, proteins that recognize a specific sequence in DNA make contact not only with individual functional groups within the base pairs of the consensus sequence recognized by the protein but usually also interact weakly with sequences flanking it. Flanking sequences contribute substantially to the binding affinity of the protein to its consensus site and the interactions can sometimes extend over two turns of the helix [3, 4] . Complications to phasing of both nucleosomes and proteins recognizing a specific sequence can arise from double stranded DNA that prefer to exist not as a straight helix but as curved or bent helixes in solution under physiological conditions [5] . Thus in order to mimic endogenous expression, it is important not only to have the consensus binding sites of specific transcription factors known to regulate the gene but also the proper context of these sites with regard to surrounding DNA.
Regulatory proteins bound to different sites along the DNA must interact with one another to transcribe the gene, possibly in a tissue-and time-specific manner and at appropriate levels doi: 10.7243/2053-5767-2-2 suitable for cell function. The distances separating such protein-bound sites along the DNA can sometimes be large, in the tens of thousands of base pairs in higher vertebrates [6, 7] . Interactions among proteins bound at different sites are thus likely to be influenced by both the length and flexibility of the intervening DNA. Bending of the intervening DNA with or without protein binding [5, 8, 9] , facilitates such interactions. Appropriate phasing of the regulatory protein bound sites with nucleosomes and other proteins that package the intervening DNA often appear necessary for optimal regulation of the gene. It is also likely that evolutionary pressures have fine-tuned the sequence variations allowed in these intervening DNA segments. Because rules governing the sequence dependence of DNA flexibility remain inadequate, and the changes difficult to predict, it is probable that the binding affinities of proteins to their DNA sites and other proteins are altered when consensus sequences are taken out of their chromosomal contexts to construct small plasmids for expressing a gene. If the gene regulatory protein exists in the cell as part of a larger protein complex, the problem can be exacerbated.
Uncertainty also arises when choosing potential generegulatory sequences to join together in a small plasmid for expressing a gene. Because many of the players that fine-tune expression of the gene remain unknown, picking regulatory sequences can introduce bias. In favorable circumstances, clues can be obtained by sequence comparisons of the gene regulatory DNA regions across different species [6, 7] . However, in situations where gene regulatory function is conserved without sequence similarity, choosing potential protein binding sequences can become a hit-or-miss affair [10] [11] [12] [13] [14] . Compounding that complexity is the fact that many regulatory proteins lack strict sequence specificity for binding DNA. This is exemplified by the TATA binding protein or the High Mobility Group (HMG) proteins which appear to recognize specific features on DNA such as minor groove accessibility and/or flexibility rather than a specific sequence [15] . Regulatory proteins such as these can present hurdles to putting together consensus binding sites in a small plasmid for expressing a gene because one does not know which sequences to use. Note also that the set of proteins regulating the expression of a gene is not unique to the gene; and combinatorial interactions between protein factors have been recognized as necessary for regulating transcription of many eukaryotic genes [15] . Thus stitching together sequences out of their chromosomal contexts might inadvertently allow combinatorial interactions of protein factors not actually involved with expression of the endogenous gene in its chromosomal context. Finally, it is important to note genes expressed from small plasmids integrated into the germline frequently suffer from position effects. Depending on the chromosomal environment, both gene silencing and altered expression can occur after transgenesis [16] [17] [18] .
Many of these hurdles can be circumvented by using BACs to explore regulation of genes by cis-acting elements. The DNA cloned in BACs, originally for mere faithful propagation of the DNA, are turning out to be the best templates for expressing genes in vertebrates. Owing to expansion of the genome in higher vertebrates during evolution, many transcription factor binding sites have been separated from one another along the DNA and from the start sites of genes. This makes BACs a convenient tool for accurate expression of the genes housed within them because they represent tiny pieces of the chromosome.
Introducing reporter genes into BACs
BACs faithfully propagate ~300,000 bp pieces of DNA from the genome of an organism in bacteria as large single copy plasmids [19] [20] [21] . Ideally, the genes contained in a BAC plasmid should be expressed in the same organism from which the chromosomal DNA was obtained for constructing the BAC library. This is largely because both the proteins and the sequences separating binding sites of protein complexes along the DNA have co-evolved for optimal function over millions of years. However, expressing genes in the same host leaves one with no features to distinguish its expression from that of the organism's genome. A reporter to tag genes from the BAC is therefore desirable, and the GFP gene is very useful for organisms that exhibit optical transparency for a significant part of their life cycle.
BACs are propagated as part of a large F-factor plasmid in the bacterial host and cannot replicate in the animal [19] . Chromosomal integration of the reporter gene-tagged BAC DNA is thus required for stable expression. In order for the BAC DNA to be truly germline, integration into the chromosome must occur at the one-cell stage of the fertilized egg during development.
Strategies for functionalizing BACs
Procedures for altering sequences in small plasmids developed during the 70's and 80's are not suitable for modifying the large DNA inserts in BACs. Strategies for altering BAC DNA differs fundamentally from those used in small plasmids for two important reasons: common restriction endo-nucleases that cut DNA at specific sequences have small recognition sites, and cut frequently in the BAC DNA to generate large numbers of fragments. Separation techniques robust enough to isolate and keep track of the relative order of these pieces in the BAC are unavailable, which precludes using the "cutand-paste" method to alter sequences. Secondly, large duplex DNA that is not packaged with DNA-binding proteins in the test tube is also very brittle, and difficult to keep intact during in vitro manipulations that generate shear forces.
Hurdles such as these can be overcome using DNA recombination in vivo. Although the net result again is cutting and re-joining of DNA ends, the entire process occurs in a concerted manner within the bacterial host with no free ends of DNA to participate in unintended biochemical reactions in the cell. It occurs primarily in a nucleoprotein complex that also doi: 10.7243/2053-5767-2-2 protects the large DNA in the BAC from shear forces.
There are two independent methods that were developed to use sequence homology for recombining DNA to alter sequences in BACs. The first approach introduced the major recombination function of E. coli, RecA [22] , back into the severely recombination deficient host bacterium DH10B engineered to propagate vertebrate DNA. Recombination is a vital function for all living organisms, and was deliberately rendered low in this bacterial host in order to prevent the vertebrate DNA in BACs from rearranging because of it containing substantial amounts of repetitive sequences. The second approach introduced the recombination functions of phage λ, namely red α, red β and red γ into the DH10B host. It has the advantage of using shorter length homologous sequences for recombination to introduce exogenous DNA cassettes into BACs [23] . Both methods have been widely used to engineer a variety of alterations in BAC DNA, such as introducing reporter gene cassettes in frame into the first exon of the target gene, mutating sequences at a target site, and introducing loxP sites [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Thus BACs of ~200 kb size and containing the β-globin gene were functionalized with EGFP reporter gene using RedET-recombination and expressed in stable erythropoietic cell lines [29] . RecA mediated homologous recombination was used to introduce a LacZ reporter gene cassette into the Gdf6 transcription unit and long-range regulatory sequences mapped using a series of BAC deletions in transgenic mice [30] . Using RecA mediated homologous recombination, 97 mixed CAA-CAG repeats were introduced into the human htt gene in a BAC to build a mouse model of huntingtin's disease [33] . Transgenic mice carrying human BAC clones with 1 kb deletions made by RedET-recombination were used to functionally identify cell lineage-specific regulatory elements 30 kb upstream of the IFNG gene [34] . Recently a moderate throughput BAC modification procedure has been described that uses RedET recombination to introduce the GFP cassette and iTol2 for integration into zebrafish chromosomes [35] . Procedures for constructing transgenic animals with functionalized BACs in mice [36] , or zebrafish [37] , have also been reviewed recently. BAC transgenisis in zebrafish to localize distal cis-acting generegulatory sequences were highlighted recently [38] .
A different way to alter sequences in BAC DNA uses transposons. It does not require homologous sequences in genomic inserts of BACs to introduce exogenous DNA cassettes. Instead, it uses a series of mobile genetic elements to first introduce exogenous DNA randomly into a BAC in its bacterial host and then position the cassette precisely at the end of the BAC DNA through a deletion triggered by CreloxP recombinations. Germ-line expression of the modified BAC in zebrafish or mice has been achieved with yet a third recombination system, namely the vertebrate Tol2 system, described later in the article. Insertions of the bacterial transposon Tn10 can introduce exogenous DNA, including lox sites, at random locations in BACs [39, 40] . Site-specific recombination by the Cre-lox system on the other hand, can deliver these reporter genes and other exogenous DNA precisely at the ends of genomic DNA inserts in BACs [41] [42] [43] . Such DNA cassettes include sequencing primer binding sites, mammalian cell-selectable antibiotic resistance genes, enhancer-traps and sequences specifically recognized by the vertebrate Tol2 transposase. It is significant that the recombinases used in our approach, Tn10-transposase and Cre protein, respectively, do not act upon repetitive sequences and/or other recombinogenic sites in the genomic DNA insert, therefore minimizing the risk of generating unwanted rearrangement products that are commonly associated with other recombination based methods. Thus BACs spanning loci with highly repetitive DNA content such as those commonly found in the human, and other vertebrate genomes, are also amenable to our methodology (see reference [41] for an example). In contrast to procedures that use sequence homology based recombination to engineer end-deletions, which can only produce one alteration at a time, our approach with loxP or lox511 transposons can generate large collections of end-deleted BACs in a single experiment [41] [42] [43] .
Insertions of the Tn10 transposon into BAC DNA from a wide variety of vertebrate genome libraries appear to be random, demonstrating little sequence specificity for transposition [41] . It is unclear whether this lack of sequence specificity arises from the absence of selective pressure evolutionarily for insertions of a prokaryotic transposon into vertebrate DNA, because insertions of Tn10 into prokaryotic DNA have long been known to prefer a somewhat degenerate nevertheless consensus insertion site [44] . The minor sequence preferences for insertions of Tn10 observed in BACs probably have more to do with the accessibility of sites for Tn10 insertions than specificity for sequences. Note that E. coli has histone-like proteins, known as HU protein, which package the vertebrate DNA in the BAC and can generate differences in accessibility for transposon insertions. Transposition of Tn10 into a rare BAC clone occasionally displays "apparent" sequence selectivity [45] . However, this result has been clearly shown to be due to a clonal selection process that arose from picking single colonies of Tn10 plasmid-transformed BAC clones that had induced the transposase gene prior to actual induction with isopropyl β-D-1-thiogalactopyranoside (IPTG). Inducing a large pool of Tn10 plasmid-transformed BAC colonies routinely was recommended, instead of a single clone, to rectify this potential problem completely [45] .
Deleting BAC ends with loxP-Tn10 transposons
The bacterial transposon Tn10 is used to introduce exogenous DNA sequences into the genomic insert of BACs as illustrated in Figure 1 . A loxP sequence is placed within the 70 base inverted repeat ends of the Tn10 mini-transposon ( Figures 1A and 1B) .
Plasmid DNA carrying the transposon is introduced into the same cell that contains the BAC plasmid. Upon induction with IPTG the expressed transposase protein excises the DNA doi: 10.7243/2053-5767-2-2 cassette flanked by the inverted repeats (shown as purple and pink boxes L & R in the Tn10 plasmid) and inserts it into other nearby DNA in the bacterial host, including the bacterial genome and the BAC DNA (shown in Figure 1C) . Insertions of Tn10 into BAC DNA occur in either orientation, and are irreversible because the transposase gene is left behind as linear DNA and destroyed. Important considerations that dictate subsequent steps of the procedure include 1) damage to the host genome from Tn10 insertions, and 2) the fraction of BACs actually modified is relatively low ~1 in 10,000. Efficient steps are thus required to recover the few BACs with Tn insertions and transfer these into a new host. Both these challenges are met by packaging the Tn10-modified BAC DNA in phage P1 heads. Therefore cells containing the BAC DNA with Tn10 insertions are infected with P1 phage after induction with IPTG.
Infection with P1 phage serves an additional purpose. The phage expresses Cre protein early in its life cycle to circularize the linear double-stranded phage DNA existing in the P1 head. Cre protein acts in trans to also recombine the loxP site transposed into the BAC DNA insert with the loxP endogenous to BAC vector and located at one end of insert DNA (Figure 1D) . Thus the transposed loxP site of one orientation produces a deletion from one end of genomic insert, while the loxP inserted in the opposite orientation simply inverts the DNA between it and the one endogenous to the BAC. The phage P1 DNA circularizes upon entry into the BAC-containing cell through Cre-recombination of its terminally redundant loxP sites [46] . It then forms a co-integrate structure with the enddeleted BAC DNA, again by recombination with Cre protein in the cell. Recovery of the end-deleted BAC is explained schematically in Figure 2 . Packaging of the end-deleted BAC DNA occurs/starts preferentially from this co-integrate structure due to the location/orientation of the phage packaging site, the "pac site". Note that the end-deleted BAC DNA needs to be less than P1-headful size in order for both loxP sites to be packaged in the P1 head. Upon infection of fresh cells with this phage, the BAC DNA is recoverable only when the DNA in the phage-head has both loxP sites to recombine to produce a circular plasmid as shown in Step 2, Figure 2 (also see [47] for detailed procedure). 
Characterization of retrofitted/end-deleted BACs

Progressive truncations from both ends of insert DNA in BACs
Genomic DNA in BACs is flanked by loxP and mutant lox511 sites [21, 49] . Genome libraries in the public domain of numerous organisms such as the mouse, rat, human and zebrafish have used the vector pBACe3.6 or its derivatives (reference [20, [50] [51] [52] , link for pTARBAC2.1 vector http://bacpac. chori.org/ptarbac21.htm), and all share this characteristic. Thus end-deletions specifically from the lox511 side of genomic insert were made using a similar approach with lox511-Tn10 mini-transposons [49] .
Cross-recombination between loxP & lox511 sites does not occur with Cre expressed by phage P1 infection
The 34 bp sequence of mutant lox511 differs from the wild type Step 1: Shows the Cre recombination of circularized phage P1 DNA (P-G-E) with the end-deleted BAC DNA (B-A-C) to generate a co-integrate. The phage packaging site "pac site" and the Cre gene are indicated in the phage DNA by the thick solid bar and the X, respectively.
Step 2: Shows the BAC DNA packaged in the phage P1 head, its recombination after entry into cells by newly synthesized Cre protein, and circularization into a BAC plasmid. If the length of DNA (B-A-C) exceeds the headful packaging capacity of ~110 kb, then the second loxP site (indicated by the thick arrows) would not fit in the phage head and the DNA cannot circularize by loxPCre recombination after entry into cells [46] . It leads to the BAC DNA not being rescued. Note that the Cre gene is also lost upon circularization of the truncated BAC DNA. loxP by one nucleotide in the spacer region (see [49, 53] , for lox511 sequence). Previous studies had reported recombination between loxP and lox511 to occur at efficiencies ranging from 5 to 100% under experimental conditions that express Cre constitutively [54] [55] [56] [57] [58] [59] . Such cross-recombination was not observed when Cre protein was expressed in a phage P1 infection in vivo [49, 60, 61] , and high levels of stringency in recombining identical lox sites [49, 60] , or lox sites with at least identical spacers was achieved [61] . Truncations of genomic DNA in a BAC from either end are not only efficient, but are specific for that end.
Introducing exogenous DNA cassettes precisely at one or both newly created BAC end
The end-deletion technology allows one to introduce reporter genes and other DNA cassettes precisely at the new end created in the BAC. Sequence in front of the loxP arrow, shown in green in Panels B & D of Figure 1 , is retained after the recombination event that creates the deletion, while that shown in yellow ( Figure 1B) is eliminated. Note that orientation of arrow refers to directionality of loxP sequence. This feature has been utilized to place numerous DNA cassettes in the BAC, such as: i) mammalian cell-selectable antibiotic resistance genes [41] , ii) a basal promoter-containing EGFP gene to serve as an enhancer-trap to functionally locate potential generegulatory elements further upstream [40] , and iii) introduce end sequences of the vertebrate transposn iTol2 to generate integration-ready GFP-functionalized BAC DNA for zebrafish or mouse transgenesis studies [43, 62] . The ability to truncate either end of a BAC insert progressively while keeping the other end intact has been very useful to a variety of mapping studies. Prior to the availability of whole genome sequences it offered probably the best means to unambiguously map genetic markers at the sequence level. Thus polymorphisms have been mapped on physical maps of chromosomes using the technology [40, 41] . Long-range regulatory elements of the mouse Nkx2-5 gene have also been mapped functionally using end-deleted EGFP functionalized BACs to generate transgenic mice [63] . More recently it has been used in enhancer-trapping using BACs.
Introducing reporter gene and truncating BAC end simultaneously
Truncation of sequences downstream of a gene while introducing the GFP reporter can be achieved simultaneously in BACs using lox-Tn10 transposons. Potential regulatory sequences upstream of the gene can then be probed by truncating BAC DNA from the other end using a lox511-Tn10 transposon. These strategies have been successfully realized to decipher the role of sequences in two distinct domains of the zebrafish appb gene in regulating its tissue-specific expression [42, 64] . A basal promoter-containing EGFP gene was designed to serve as an enhancer-trap, and placed in front of the loxP arrowhead such that the cassette was retained after the end-deletion ( Figure 3A) . Deleting progressively from one end of BAC insert containing the appb gene with this enhancer-trap transposon (the right hand end in this case) generated a library of BACs that differ in location of the enhancer-trap with respect to the start site of transcription of the gene. The collection of well characterized BAC DNA was introduced individually into zebrafish embryos for expression of the gene in specific tissues.
Once a distal DNA domain at -31 kb had been tentatively identified as enhancing transcription of the appb gene, progressive truncations from the opposite end were made with a lox511 transposon to confirm the finding [64] . Truncation from the opposite end and insertion of the ends of the vertebrate transposon iTol2, required for chromosomal integration of the BAC DNA, were done simultaneously using a lox511-iTol2kan Tn10 transposon as illustrated in Figure 3B and summarized below.
Integrating BAC DNA into the germline of zebrafish and mice using Tol2
Germline integration of BAC DNA in zebrafish was achieved using Tol2 [37, 38, 43] . Originally isolated from medaka fish, Tol2 is a vertebrate transposon system that functions effectively in zebrafish and mice [62] . Traditionally, Tol2 ends in the inverted orientation and flanking a 1 kb spacer DNA (iTol2) were introduced into BAC DNA using recombination of homologous sequences between targeting vector and the genomic insert [37, 62] . To avoid potential complications from rearrangement of highly repetitive DNA that occurs in certain BACs from higher vertebrate genome libraries (see for example the mouse Npr3 gene locus analyzed earlier [41] ), a simpler and more widely applicable approach has been developed using Tn10 transposons to deliver iTol2 ends into BACs [43] . The iTol2kan DNA is inserted by a lox511Tn10 transposon to the lox511 end of the enhancer-trap BAC as shown schematically in Figure 3B . As a bonus it generates, in a single experiment, a large collection of end-deleted integration-ready BACs. These are ideally suited for functionally mapping distal regulatory sequences of a gene when individual members from the deletion library are expressed in zebrafish or mouse embryos [43] .
Dissecting amyloid precursor protein (appb) gene regulation in zebrafish
Application of several components of the Tn10 transposon BAC retrofitting technology described above to functionally identify distal non-contiguous regulatory elements of the zebrafish appb gene is illustrated below. Zebrafish has gained popularity as a model system in recent years due to a variety of reasons, which include optical transparency of its embryo. This is despite the fact that it is further removed from humans than mice evolutionarily. The model has been used to explore the function of highly conserved non-coding DNA in vertebrates, which is often found tens of thousands of base-pairs removed from the start sites of genes [6, 7] . However, doi: 10.7243/2053-5767-2-2 functional non-coding DNA is sometimes not conserved in many developmentally regulated genes including appb [42, 64] . Identifying regulatory DNA domains in the appb gene has therefore been a challenge. The enhancer-trap approach is particularly useful in such circumstances because it allows one to scan a series of overlapping BACs to identify gene-regulatory sites without having to guess potential regulatory sites to test. Thus, using only a basal promoter driven EGFP gene in a loxP-Tn10 enhancer-trap transposon to scan appb gene-containing BACs the requirement of an intron enhancer was established initially [42] . In the absence of this enhancer there is no expression of a BAC transgene that contained approximately 100 kb of 5' sequences [42] . It's an important necessary condition for the existence of an enhancer downstream of the transcription start site of appb gene. [64] . After characterization suitable BACs from the library are expressed individually in zebrafish embryos. Expression analysis of a large number of enhancer-trap appb BACs indicates that ~31 kb of DNA immediately upstream of the appb transcription start site is important for neuronal expression of appb: in its presence expression is neuronal (inset), while in its absence expression switches to the notochord of zebrafish (inset). Injection of enhancer-trap transposon plasmid DNA itself, without the BAC, also gives this notochord expression pattern [42] . (B) Schematic representation of insertion of the Tnlox511-iTol2kan transposon into enhancer-trap BAC DNA: The iTol2 cassette is located in front of the lox511 arrowhead. Insertion of ends of the vertebrate transposon iTol2 renders these enhancer-trap BACs integration ready [62] . The red and purple arrowheads pointing outward in the iTol2kan cassette correspond to the 200 bp inverted repeat end R and 150 bp inverted repeat end L of the Tol2 transposon [43, 64] . doi: 10.7243/2053-5767-2-2 intron 1 enhancer required to express appb in a pattern similar to the endogenous gene in neurons of zebrafish [42] . These experiments highlighted the importance of a second regulatory region located between 28 and 31 kb upstream of the gene for guiding appb expression to neurons. Deleting this upstream region shifted the expression pattern from being neuron-specific to notochord-specific, which is the default pattern observed with the basal promoter plus intron enhancer combination. Consistent with this finding the expression of GFP in neurons of enhancer-trap BACs with a full complement of upstream sequences reverted to specific expression in the notochord when the three E4BP4 sites at -31 kb of zebrafish appb was deleted with a Tnlox511-iTol2kan transposon from the opposite end of BAC DNA (Figure 3) . These upstream sites also bound the E4BP4 DNA binding protein domain, expressed in E. coli, efficiently and selectively in vitro [64] .
Binding sites of transcription factor E4BP4/NFIL3 required for regulating appb
Expression of enhancer-trap BACs containing mutated intron 1 enhancers was analyzed next. A select group of enhancertrap BACs from 18 libraries, constructed with mutated intron 1 enhancers was expressed in zebrafish. The results indicated binding sites of at least two known transcription factors are important for function. They are the clock-regulated and immune system modulator transcription factor E4BP4/ NFIL3 and members of the Forkhead gene family (XFD1). A search of non-coding DNA in introns and the 50 kb sequence surrounding the appb gene for additional binding sites revealed a ~8-fold and ~11-fold greater frequency than statistical of E4BP4 and XFD1 sites, respectively. Although comparison of zebrafish and human APP did not reveal substantially conserved non-coding sequences that could represent regulatory elements, conservation of gene expression via the use of the same transcription factors was proposed. Overrepresentation of E4BP4 binding sites at the human APP locus supports such a hypothesis (Figure 4) . Strikingly, one such cluster of four E4BP4 sites in the fourth intron of the human APP gene was marked by a peak of acetylated histones in a human neuroblastoma cell line that expressed APP [64] . Thus it appears that E4BP4/NFIL3 may regulate human APP expression via binding to distal regulatory sequences. Higher than statistical frequency of E4BP4/NFIL3 sites have also been noted in both mouse (13 sites), and rat (10 sites) APP (unpublished observations).
Transcription factor E4BP4/NFIL3 is clock regulated [65, 66] , and intricately linked with the immune system, where it is required for protecting natural killer (NK) T cells [67] and regulates IL-12 p40 in macrophages [68] . If it were to also regulate human APP expression then it would offer a ready explanation not only for the circadian pattern observed for β-amyloid levels in mice brains [69] , but also the importance of immunological and inflammatory processes in Alzheimer's Disease in humans [70] .
Regulation of appb in zebrafish and APP in humans by the forkhead family of transcription factors
Earlier studies had indicated certain members of the forkhead family of transcription factors, (fkd1, fkd2 and fkd4), are expressed during gastrulation in the zebrafish, with high levels of fkd1 and fkd4 mRNA accumulating exclusively in the notochord during somitogenesis [71] . It suggested that the fkd1, fkd2 and fkd4 proteins are available only in the notochord and could explain the expression of EGFP exclusively in the notochord when the cluster of three E4BP4/NFIL3 sites at -31 kb are deleted in the enhancer-trap appb-BACs [42, 64] . A suppressor role for E4BP4/NFIL3 is consistent with this scenario and supported by recent reports [65, 72] . The forkhead binding site in intron 1 enhancer required for function and the much higher than statistical frequency of forkhead sites in and around the appb gene suggest a regulatory role for this family of transcription factors [64] . Over-representation of fkd sites is however absent in human APP: although there are only two sites with the XFD1 consensus sequence, sites with 8 of 9 bases identical (consecutively) to the consensus exist far more abundantly in human APP (13 additional such sites were identified, designated as XFD2 and shown below in Figure 4) , leading us to speculate that Fkd protein complexes potentially capable of binding to such sites might have evolved to accommodate the single endnucleotide change. We are currently assessing this hypothesis.
E4BP4 (E), XFD1 (X) & XFD2 (Y) site at human APP locus sites analyzed by ChIP
A novel interplay between Fkd and E4BP4/NFIL3 is proposed to restrict expression of appb to neurons of zebrafish, either directly or indirectly through other proteins. The findings, taken together, would suggest that appb in zebrafish and APP in humans may follow the same regulatory logic using the same set of transcription factors, despite a lack of sequence similarity in their regulatory DNA. It suggests potential regulatory pathways for the human APP gene may be discovered not on the basis of comparing DNA primary sequences with zebrafish appb, but on the model of conservation of transcription factors.
Unique advantages of using enhancer-trap BACs for exploring gene regulation by distal cis-acting DNA domains
Because BACs represent tiny pieces of the chromosome, they offer a large enough contiguous span of DNA to house most of the sequences required to regulate expression of a gene. But more importantly, the protein-binding sites in the BAC DNA exist in their chromosomal contexts, ie. sequence flanking important transcription factor binding sites, which have evolved for millions of years, are preserved. Therefore a general approach to retrofit BACs to equip them with enhancer-traps was developed such that cis-acting regulatory sequences could be easily identified by expressing a series of end-truncated BACs in animals [42] . Because all members of the deletion library contain identical changes at the loxP or lox511 end, comparisons of expression patterns between any two enhancer-trap BACs from the same deletion series are more meaningful as the modifications in each remain constant. Thus BACs can be "scanned" with enhancer-traps to identify distal regulatory elements; and this approach is likely to be less biased than other methods where mutations are targeted to specific sites in the BAC because there is no need to select sequences to test their regulatory potential [30] [31] [32] 34] . In situations where regulatory function is conserved without sequence similarity [10] [11] [12] [13] [14] , choosing the correct sequence to test might be very difficult as many of the players involved in fine tuning the regulation of gene expression remain unknown.
The BAC enhancer-trap technology has three distinctive features that should prove beneficial: i) much larger sequences of DNA can be probed, including multiple regulatory domains that are discontinuous, and often act together to regulate expression of higher vertebrate genes such as appb. Note that the enhancer sequences in intron 1 and the -31 kb upstream region in appb are separated by some 35 kb of DNA [64] . Gene regulation of this type would be far more tedious to analyze using other BAC recombineering approaches. ii) is less biased compared to targeted approaches as noted above, and iii) compared to traditional enhancer-trapping that use whole genomes of animals, our approach is not affected by genome accessibility issues of the trap during the one-cell stage of the embryo. Traditional methods for enhancer-trapping have used either a retroviral vector or other vertebrate transposable element to insert the trap directly into whole genomes of animals, or integrate test-sequences cloned in a small vector into the germline using a vertebrate transposon such as Tol2 [73] [74] [75] [76] [77] [78] [79] . Using test-sequences is a "targeted" approach, and thus not free of the investigators' biases. Additionally, the traditional methods require the enhancer-trap be introduced into the fertilized egg at the one-cell stage for germline expression. Some regions of the genome are more accessible than others for insertion of the enhancer-trap at this stage of development of the egg, and because one cannot have multiple insertions of the same trap for an unambiguous analyses, most of the genome remains unreachable. Consequently enhancers have been identified in only a very small percentage of the genome in animals studied, and vast regions appear refractory to enhancer-trapping by traditional means. By contrast, the Tn10 approach requires inserting the trap in isolated pieces of chromosomal DNA in BACs in the bacterial host. Therefore a much greater fraction, probably all, of the genome is potentially accessible for study because to date BACs refractory to Tn10 transposon insertions have not been encountered. Although the functional context of transcription factor binding sites identified this way is limited to the size of BACs, using enhancer-traps to scan individual BACs allows a more uniform coverage of the genome. This is because the baseline efficiency of trap insertion is reset for individual BACs in the bacterial host. Additionally, mutations of transcription factor binding sites in the BAC can be more easily introduced via a small Tn10 transposon plasmid, which can then be inserted into BAC DNA as demonstrated for functionally dissecting the intron 1 enhancer of appb gene [64] .
However when comparing the enhancer-trap approach as used in BACs to that when used in the entire genome, such as in whole-genome screens, it is probably important to also remember that the goals in the two are usually different. With a BAC, the goal is usually to generate a specific reporter for a gene of interest or to dissect regulatory elements for a specific gene. The whole-genome approach on the other hand is usually doi: 10.7243/2053-5767-2-2 for high-throughput screening in vivo to recover numerous useful enhancer-trap reporter lines [73] [74] [75] [76] [77] .
The context dependence of enhancers has been underscored in recent reports. It has been conjectured that the regulatory properties of an isolated enhancer could be quite different than when it is in the context of its own gene [80] . The intron enhancer of appb discussed here serves as one of the clearest examples of an enhancer element directing expression to two completely different tissues based upon its context [42, 64] . 
